Cell Therapy Technologies Market Research 2024 - Industry Analysis, Size, Share, Future Trends, Growth Opportunities And Forecast 2033

The new report published by The Business Research Company, titled Cell Therapy Technologies Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the cell therapy technologies market size has grown rapidly in recent years. It will grow from $4.29 billion in 2023 to $4.97 billion in 2024 at a compound annual growth rate (CAGR) of 15.8%. The cell therapy technologies market size is expected to see rapid growth in the next few years. It will grow to $8.62 billion in 2028 at a compound annual growth rate (CAGR) of 14.8%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=4122&type=smp

Government Investments Drive Growth In Global Cell Therapy Technologies Market For Disease Treatments
Increasing investments by the government in cell-based research contributed to the growth of the global cell therapy technologies market. Governments are increasingly investing in research activities for developing therapies for diseases such as cancer, cardiovascular disease (CVD), and others. For instance, in May 2022, The California Institute for Regenerative Medicine (CIRM), a research center helping stem cell research invested more than $11 million to fund a clinical trial for a cell therapy for the treatment of throat cancer. The success of this therapy will save patients from undergoing radiotherapy and its side effects.

Companies Pioneer Advanced Technologies In The Cell Therapy Technologies Market
Major companies operating in the cell therapy technologies market are developing innovative products by using advanced technologies to grow in the market. For instance, in June 2022, Invetech, an Australia-based company that specializes in the design, engineering, and manufacture of commercial-scale diagnostic products and cell and gene therapies launched Korus, a new closed system for autologous cell therapies, to transform the industry standards in elutriation and cell wash. The technology uses a mild elutriation process to supply a cleaner cell population for cell therapy production processes, such as tumor-infiltrated lymphocytes (TIL), dendritic cells, chimeric antigen receptor (CAR)-T cell or induced pluripotent stem cell (IPSC)-derived therapy. It features elutriation and cell wash using gentle counterflow centrifugation and provides purified cell populations for downstream processing development and commercial manufacture. This will help improve the overall performance of processes through higher recovery and purity of target cells. Using the new Korus system, developers can expedite the clinical development and scale-up of their products.

The cell therapy technologies market covered in this report is segmented -

1) By Product: Consumables, Equipment, Systems And Software
2) By Cell Type: T-Cells, Stem Cells, Other Cells
3) By Process: Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control
4) By End User: Life Science Companies, Research Institutes And Cell Banks

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=4122&type=discount

Major companies operating in the cell therapy technologies market report are Lonza Group AG, Thermo Fisher Scientific Inc, Merck KGaA, Terumo Corporation, Danaher Corporation, Fresenius Medical Care AG & Co. KGaA, Fujifilm Holdings Corporation, Sartorius AG, Becton Dickinson and Company, Avantor Inc., Cellular Biomedicine Group, CORESTEM, Astellas Pharma Inc, Anterogen Co. Ltd, Arce Therapeutics, CARsgen Therapeutics, Huadong Medicine, Co.Don AG, AstraZeneca, Neogene Therapeutics, GammaDelta Therapeutics Limited, Nightstar, SOTIO, Accell Clinical Research, Genestack, Novartis AG, Pfizer, Celgene Corporation, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Bayer AG, Gilead Sciences, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Amgen, Regen BioPharma, Bellicum, Amgen Brazil, GlaxoSmithKline plc, Biogen Brazil, Takeda Pharmaceutical Company Limited, Pfizer S.R.L, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Bayer East Africa Ltd, Adcock Ingram, Next BioSciences, CryoSave, BioHeart, Stem Cell Technologies.

Contents of the report:
1. Executive Summary
2. Cell Therapy Technologies Market Report Structure
3. Cell Therapy Technologies Market Trends And Strategies
4. Cell Therapy Technologies Market - Macro Economic Scenario
5. Cell Therapy Technologies Market Size And Growth
…..
27. Cell Therapy Technologies Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.